AbbVie Inc. diskutieren
AbbVie Inc.
WKN: A1J84E / Symbol: ABBV / Name: AbbVie / Aktie / Pharmazeutika / Large Cap /
175,04 €
-0,08 %
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Morgan Stanley from $189.00 to $193.00. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $170.00 price target on the stock, up previously from $160.00.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Morgan Stanley from $193.00 to $196.00. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Raymond James from $177.00 to $181.00. They now have an "outperform" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Barclays PLC from $170.00 to $175.00. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Barclays PLC from $175.00 to $185.00. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Raymond James from $181.00 to $189.00. They now have an "outperform" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at BMO Capital Markets from $187.00 to $195.00. They now have an "outperform" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Truist Financial Co. from $180.00 to $195.00. They now have a "buy" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Guggenheim from $188.00 to $190.00. They now have a "buy" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Barclays PLC from $185.00 to $195.00. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target lowered by analysts at BMO Capital Markets from $195.00 to $180.00. They now have an "outperform" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target lowered by analysts at Barclays PLC from $195.00 to $187.00. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $200.00 price target on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $185.00 price target on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Piper Sandler from $185.00 to $190.00. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $200.00 price target on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $190.00 price target on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its "overweight" rating re-affirmed by analysts at Piper Sandler Companies. They now have a $190.00 price target on the stock.
Ratings data for ABBV provided by MarketBeat
Neueste Beiträge
Evercore_ISI in Boston Properties diskutieren